Sarissa Capital Management LP Portfolio Holdings
Sarissa Capital Management LP
- $402 Million
- Q3 2024
Sarissa Capital Management LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $402 Million distributed in 10 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Innoviva, Inc. with a value of $140M, Ironwood Pharmaceuticals Inc with a value of $67.4M, Gilead Sciences, Inc. with a value of $64M, Cytokinetics Inc with a value of $58.6M, and Neurocrine Biosciences Inc with a value of $47.3M.
Examining the 13F form we can see an decrease of $190M in the current position value, from $592M to 402M.
Sarissa Capital Management LP is based out at Greenwich, CT
Below you can find more details about Sarissa Capital Management LP portfolio as well as his latest detailed transactions.